Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 40

1.

Transfusional iron overload and intravenous iron infusions modify the mouse gut microbiota similarly to dietary iron.

La Carpia F, Wojczyk BS, Annavajhala MK, Rebbaa A, Culp-Hill R, D'Alessandro A, Freedberg DE, Uhlemann AC, Hod EA.

NPJ Biofilms Microbiomes. 2019 Sep 24;5:26. doi: 10.1038/s41522-019-0097-2. eCollection 2019.

2.

Increased erythrophagocytosis induces ferroptosis in red pulp macrophages in a mouse model of transfusion.

Youssef LA, Rebbaa A, Pampou S, Weisberg SP, Stockwell BR, Hod EA, Spitalnik SL.

Blood. 2018 Jun 7;131(23):2581-2593. doi: 10.1182/blood-2017-12-822619. Epub 2018 Apr 17.

3.

Prolonged red cell storage before transfusion increases extravascular hemolysis.

Rapido F, Brittenham GM, Bandyopadhyay S, La Carpia F, L'Acqua C, McMahon DJ, Rebbaa A, Wojczyk BS, Netterwald J, Wang H, Schwartz J, Eisenberger A, Soffing M, Yeh R, Divgi C, Ginzburg YZ, Shaz BH, Sheth S, Francis RO, Spitalnik SL, Hod EA.

J Clin Invest. 2017 Jan 3;127(1):375-382. doi: 10.1172/JCI90837. Epub 2016 Dec 12.

4.

Competitive intramolecular C-C vs. C-O bond coupling reactions toward C6 ring-fused 2-pyridone synthesis.

Lepitre T, Pintiala C, Muru K, Comesse S, Rebbaa A, Lawson AM, Daïch A.

Org Biomol Chem. 2016 Apr 14;14(14):3564-73. doi: 10.1039/c6ob00303f. Epub 2016 Mar 15.

PMID:
26976735
5.

Identification, mechanism of action, and antitumor activity of a small molecule inhibitor of hippo, TGF-β, and Wnt signaling pathways.

Basu D, Lettan R, Damodaran K, Strellec S, Reyes-Mugica M, Rebbaa A.

Mol Cancer Ther. 2014 Jun;13(6):1457-67. doi: 10.1158/1535-7163.MCT-13-0918. Epub 2014 Apr 2.

6.

Histone acetylation-mediated regulation of the Hippo pathway.

Basu D, Reyes-Múgica M, Rebbaa A.

PLoS One. 2013 May 6;8(5):e62478. doi: 10.1371/journal.pone.0062478. Print 2013.

7.

OT-404, multi-targeted anti-cancer agent affecting tumor proliferation, chemo-resistance, and angiogenesis.

Rebbaa A, Patil G, Yalcin M, Sudha T, Mousa SA.

Cancer Lett. 2013 May 10;332(1):55-62. doi: 10.1016/j.canlet.2013.01.016. Epub 2013 Jan 21.

PMID:
23348692
8.

Role of the beta catenin destruction complex in mediating chemotherapy-induced senescence-associated secretory phenotype.

Basu D, Reyes-Mugica M, Rebbaa A.

PLoS One. 2012;7(12):e52188. doi: 10.1371/journal.pone.0052188. Epub 2012 Dec 18.

9.

Dual targeting of the antagonistic pathways mediated by Sirt1 and TXNIP as a putative approach to enhance the efficacy of anti-aging interventions.

Mousa SA, Gallati C, Simone T, Dier E, Yalcin M, Dyskin E, Thangirala S, Hanko C, Rebbaa A.

Aging (Albany NY). 2009 Mar 31;1(4):412-24.

10.

The anti-angiogenic activity of NSITC, a specific cathepsin L inhibitor.

Rebbaa A, Chu F, Sudha T, Gallati C, Dier U, Dyskin E, Yalcin M, Bianchini C, Shaker O, Mousa SA.

Anticancer Res. 2009 Nov;29(11):4473-81.

11.

Stress resistant human embryonic stem cells as a potential source for the identification of novel cancer stem cell markers.

Mousa SA, Sudha T, Dyskin E, Dier U, Gallati C, Hanko C, Chittur SV, Rebbaa A.

Cancer Lett. 2010 Mar 28;289(2):208-16. doi: 10.1016/j.canlet.2009.08.018. Epub 2009 Sep 4.

PMID:
19733430
12.

Cathepsin L inhibition suppresses drug resistance in vitro and in vivo: a putative mechanism.

Zheng X, Chu F, Chou PM, Gallati C, Dier U, Mirkin BL, Mousa SA, Rebbaa A.

Am J Physiol Cell Physiol. 2009 Jan;296(1):C65-74. doi: 10.1152/ajpcell.00082.2008. Epub 2008 Oct 29.

13.

Role of the proteolytic hierarchy between cathepsin L, cathepsin D and caspase-3 in regulation of cellular susceptibility to apoptosis and autophagy.

Zheng X, Chu F, Mirkin BL, Sudha T, Mousa SA, Rebbaa A.

Biochim Biophys Acta. 2008 Dec;1783(12):2294-300. doi: 10.1016/j.bbamcr.2008.07.027. Epub 2008 Aug 13.

14.

Cellular conditioning with trichostatin A enhances the anti-stress response through up-regulation of HDAC4 and down-regulation of the IGF/Akt pathway.

Chu F, Chou P, Mirkin BL, Mousa SA, Rebbaa A.

Aging Cell. 2008 Aug;7(4):516-25. doi: 10.1111/j.1474-9726.2008.00403.x. Epub 2008 Jul 8.

15.

Novel function of the thyroid hormone analog tetraiodothyroacetic acid: a cancer chemosensitizing and anti-cancer agent.

Rebbaa A, Chu F, Davis FB, Davis PJ, Mousa SA.

Angiogenesis. 2008;11(3):269-76. doi: 10.1007/s10456-008-9110-8. Epub 2008 Apr 4.

PMID:
18386142
16.

Tetraiodothyroacetic acid, a small molecule integrin ligand, blocks angiogenesis induced by vascular endothelial growth factor and basic fibroblast growth factor.

Mousa SA, Bergh JJ, Dier E, Rebbaa A, O'Connor LJ, Yalcin M, Aljada A, Dyskin E, Davis FB, Lin HY, Davis PJ.

Angiogenesis. 2008;11(2):183-90. Epub 2007 Dec 13.

PMID:
18080776
17.

The role of histone acetylation versus DNA damage in drug-induced senescence and apoptosis.

Rebbaa A, Zheng X, Chu F, Mirkin BL.

Cell Death Differ. 2006 Nov;13(11):1960-7. Epub 2006 Mar 24.

18.

Control of multidrug resistance gene mdr1 and cancer resistance to chemotherapy by the longevity gene sirt1.

Chu F, Chou PM, Zheng X, Mirkin BL, Rebbaa A.

Cancer Res. 2005 Nov 15;65(22):10183-7.

19.

Identification of midkine as a mediator for intercellular transfer of drug resistance.

Mirkin BL, Clark S, Zheng X, Chu F, White BD, Greene M, Rebbaa A.

Oncogene. 2005 Jul 21;24(31):4965-74.

PMID:
15897897
20.

Targeting senescence pathways to reverse drug resistance in cancer.

Rebbaa A.

Cancer Lett. 2005 Feb 28;219(1):1-13. Review.

PMID:
15694659
21.

Modulation of Growth Factor response in brain tumors by complex carbohydrates.

Rebbaa A, Chou PM, Bremer EG.

Bull Cancer. 2004 Apr;91(4):E15-60. Review.

22.

Senescence-initiated reversal of drug resistance: specific role of cathepsin L.

Zheng X, Chou PM, Mirkin BL, Rebbaa A.

Cancer Res. 2004 Mar 1;64(5):1773-80.

23.

Caspase inhibition switches doxorubicin-induced apoptosis to senescence.

Rebbaa A, Zheng X, Chou PM, Mirkin BL.

Oncogene. 2003 May 8;22(18):2805-11.

PMID:
12743603
24.
25.

Doxorubicin-induced apoptosis in caspase-8-deficient neuroblastoma cells is mediated through direct action on mitochondria.

Rebbaa A, Chou PM, Emran M, Mirkin BL.

Cancer Chemother Pharmacol. 2001 Dec;48(6):423-8.

PMID:
11800021
27.

Expression of bisecting GlcNAc in pediatric brain tumors and its association with tumor cell response to vinblastine.

Rebbaa A, Chou PM, Vucic I, Mirkin BL, Tomita T, Bremer EG.

Clin Cancer Res. 1999 Nov;5(11):3661-8.

28.

Sialidase gene transfection enhances epidermal growth factor receptor activity in an epidermoid carcinoma cell line, A431.

Meuillet EJ, Kroes R, Yamamoto H, Warner TG, Ferrari J, Mania-Farnell B, George D, Rebbaa A, Moskal JR, Bremer EG.

Cancer Res. 1999 Jan 1;59(1):234-40.

29.

Very low density lipoproteins and interleukin 2 enhance the immunogenicity of 9-O-acetyl-GD3 ganglioside in BALB/c mice.

Dumontet C, Rebbaa A, Portoukalian J.

J Immunol Methods. 1997 Aug 7;206(1-2):115-23.

PMID:
9328574
30.

alpha2,6-Sialyltransferase gene transfection into a human glioma cell line (U373 MG) results in decreased invasivity.

Yamamoto H, Kaneko Y, Rebbaa A, Bremer EG, Moskal JR.

J Neurochem. 1997 Jun;68(6):2566-76.

31.

Gene transfection-mediated overexpression of beta1,4-N-acetylglucosamine bisecting oligosaccharides in glioma cell line U373 MG inhibits epidermal growth factor receptor function.

Rebbaa A, Yamamoto H, Saito T, Meuillet E, Kim P, Kersey DS, Bremer EG, Taniguchi N, Moskal JR.

J Biol Chem. 1997 Apr 4;272(14):9275-9.

33.

Ganglioside GM3 inhibition of EGF receptor mediated signal transduction.

Rebbaa A, Hurh J, Yamamoto H, Kersey DS, Bremer EG.

Glycobiology. 1996 Jun;6(4):399-406.

PMID:
8842703
34.
35.
37.

Inhibition of immune cell proliferation and cytokine production by lipoprotein-bound gangliosides.

Dumontet C, Rebbaa A, Bienvenu J, Portoukalian J.

Cancer Immunol Immunother. 1994 May;38(5):311-6.

PMID:
8162613
38.

Characterization of gangliosides from normal and osteoarthritic human articular cartilage.

David MJ, Portoukalian J, Rebbaa A, Vignon E, Carret JP, Richard M.

Arthritis Rheum. 1993 Jul;36(7):938-42.

PMID:
8318040
39.

Kinetics and organ distribution of [14C]-sialic acid-GM3 and [3H]-sphingosine-GM1 after intravenous injection in rats.

Dumontet C, Rebbaa A, Portoukalian J.

Biochem Biophys Res Commun. 1992 Dec 30;189(3):1410-6.

PMID:
1482356
40.

Characterization of a monoclonal antibody that specifically binds to choline phospholipids and its use in immunocytochemistry.

Mark MP, Tsuji T, Portoukalian J, Rebbaa A, Zidan G, Ruch JV.

J Histochem Cytochem. 1992 Jun;40(6):827-38.

PMID:
1375239

Supplemental Content

Loading ...
Support Center